Aporphine and oxoaporphine compounds and pharmaceutical use thereof
申请人:——
公开号:US20040198759A1
公开(公告)日:2004-10-07
The invention provides aporphine and oxoaporphine compounds that have endothelial nitric oxide synthase (eNOS) maintaining or enhancing activities and may be used to manufacture a medicaments for preventing or treating ischemic diseases in human and mammal, and the ischemic diseases may include ischemic cerebral apoplexy, ischemic cerebral thrombosis, ischemic cerebral embolism, hypoxic ischemic encephlopathy, ischemic cardiac disease or ischemic enteropathy etc.
Manganese(III) acetate mediated oxidation of aporphines: a convenient and useful synthesis of oxoaporphines
作者:Om V. Singh、Wei-Jan Huang、Chung-Hsiung Chen、Shoei-Sheng Lee
DOI:10.1016/j.tetlet.2007.09.096
日期:2007.11
Manganese(III) acetate mediated oxidation of aporphines to oxoaporphines is described. The developed methodology was conveniently applied for the synthesis of naturally occurring oxoaporphine alkaloids, oxoglaucine, and atheroline, starting from commercially available boldine.